LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

Search

Guardant Health Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

92.6 -0.43

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

90.23

Max

96.26

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-36M

-128M

Pardavimai

16M

281M

Pelnas, tenkantis vienai akcijai

-0.5

Pelno marža

-45.684

Darbuotojai

2,490

EBITDA

-37M

-119M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+42.53% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-04-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-1.5B

12B

Ankstesnė atidarymo kaina

93.03

Ankstesnė uždarymo kaina

92.6

Naujienos nuotaikos

By Acuity

50%

50%

168 / 351 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

Guardant Health Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-05 23:01; UTC

Uždarbis

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises - Update

2026-03-05 21:54; UTC

Uždarbis

Costco Posts Higher 2Q Profit on Rising Sales, Membership Fees

2026-03-05 21:35; UTC

Pagrindinės rinkos jėgos

ServiceNow Shares Rise After CEO Says AI Can Add Value to Software

2026-03-06 00:00; UTC

Svarbiausios naujienos

Its Missile Threat Degraded, Iran Is Taking Fewer Shots at More Targets -- WSJ

2026-03-05 23:46; UTC

Rinkos pokalbiai

Nikkei May Decline Amid Concerns About Energy Costs -- Market Talk

2026-03-05 23:33; UTC

Rinkos pokalbiai

Gold Edges Higher on Possible Technical Recovery -- Market Talk

2026-03-05 23:27; UTC

Rinkos pokalbiai

Middle East Fighting Will Prompt RBA to Delay Hike -- Market Talk

2026-03-05 22:54; UTC

Rinkos pokalbiai
Uždarbis

Costco Sold a $150,000 Diamond Ring in 2Q -- Market Talk

2026-03-05 22:50; UTC

Rinkos pokalbiai

Woodside Has More Exposure to Rising Gas Prices Than Santos -- Market Talk

2026-03-05 22:48; UTC

Uždarbis

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

2026-03-05 22:46; UTC

Uždarbis

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises -- Update

2026-03-05 22:44; UTC

Uždarbis

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

2026-03-05 21:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-03-05 21:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-03-05 21:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-05 21:35; UTC

Uždarbis

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

2026-03-05 21:32; UTC

Uždarbis

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

2026-03-05 21:26; UTC

Uždarbis

These Stocks Are Today's Movers: Broadcom, Trade Desk, Berkshire Hathaway, Rigetti, Corning, Ciena, Expedia, and More -- Barrons.com

2026-03-05 21:24; UTC

Uždarbis

Costco February Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 20.8% >COST

2026-03-05 21:23; UTC

Uždarbis

Costco February Same-Store Sales Ex-Changes in Gas and Foreign Exchange Rose 7% >COST

2026-03-05 21:22; UTC

Uždarbis

Costco 2Q Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

2026-03-05 21:21; UTC

Uždarbis

Costco February Digitally-Enabled Sales Rose 21.8% >COST

2026-03-05 21:21; UTC

Uždarbis

Costco Total Co Comparable Sales for February Rose 7.9% >COST

2026-03-05 21:20; UTC

Uždarbis

Costco February Net Sales Were $21.69 B >COST

2026-03-05 21:20; UTC

Uždarbis

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

2026-03-05 21:20; UTC

Uždarbis

Costco Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

2026-03-05 21:19; UTC

Uždarbis

Costco 2Q Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 21.7% >COST

2026-03-05 21:18; UTC

Uždarbis

Costco 2Q Digitally-Enabled Sales Rose 22.6% >COST

2026-03-05 21:18; UTC

Uždarbis

Costco 2Q Same-Store Sales Up 7.4% >COST

2026-03-05 21:15; UTC

Uždarbis

Costco 2Q EPS $4.58 >COST

Akcijų palyginimas

Kainos pokytis

Guardant Health Inc Prognozė

Kainos tikslas

By TipRanks

42.53% į viršų

12 mėnesių prognozė

Vidutinis 132.58 USD  42.53%

Aukščiausias 175 USD

Žemiausias 110 USD

Remiantis 21 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Guardant Health Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

21 ratings

20

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

38.86 / 47.41Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

168 / 351 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research; and with ConcertAI to form first data-as-a-service that integrates clinical and tumor profiling data to accelerate cancer therapy research and development. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
help-icon Live chat